Clinical Trials Directory

Trials / Completed

CompletedNCT05641103

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

Status
Completed
Phase
Study type
Observational
Enrollment
122 (actual)
Sponsor
Fundación Española de Hematología y Hemoterapía · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study of splenomegaly, and the follow-up of splenectomized patients, is one of the causes of referral of these patients to pediatric gastroenterology and oncohematology clinics, and adult internal medicine and hematology. It has been described that 0.3% of hospital admissions is for this reason. The study and management of splenomegaly is well described among the different medical specialties to which these patients arrive. After the application of the different algorithms and the different studies that are carried out, these splenomegaly are identified as being of hepatic, infectious, inflammatory, congestive, hematological origin and primary causes. Despite these studies of splenomegaly, approximately 10-15% of these patients still remain undiagnosed. The objective of the present study is to increase the diagnostic sensitivity of these unknown splenomegalys, or unknown splenomegaly patients who remain in consultations, using the usual diagnostic clinical procedures of unknown splenomegaly and unknown splenectomy patients, where the investigators include the extraction of a blood sample for dry drop test (DBS), where the determination of the enzymatic/genetic activity will be carried out for Gaucher disease (GD) and acid sphingomyelinase deficiency (ASMD) , analysis of LisoGl1 and LisoSM.

Conditions

Interventions

TypeNameDescription
OTHERPatient with splenomegaly or splenectomyNo interventional study

Timeline

Start date
2023-03-21
Primary completion
2024-09-30
Completion
2024-10-31
First posted
2022-12-07
Last updated
2026-02-19

Locations

14 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05641103. Inclusion in this directory is not an endorsement.